T1	Participants 207 261	adults with smear-positive pulmonary tuberculosis (TB)
T2	Participants 324 460	human immunodeficiency virus (HIV) infected participants who were not receiving antiretroviral therapy (ART) at TB treatment initiation.
T3	Participants 695 794	Of 750 participants who received at least one dose of study treatment, 123 (16%) were HIV-infected.
T4	Participants 1029 1054	HIV-infected participants
T5	Participants 1195 1220	HIV-infected participants
T6	Participants 1374 1394	HIV-infected persons
T7	Participants 1558 1578	HIV-infected persons
